Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 5c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $574 thousand versus the consensus estimate of $190 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Pulse Biosciences (PLSE) PT Raised to $35 at Oppenheimer
• FMC Corp. (FMC) Tops Q2 EPS by 4c; lowers guidance
• Agnico Eagle Mines (AEM) Misses Q2 EPS by 3c